GLAXOSMITHKLINE is investing £230million in a US gene profiling company 23andMe, best known for saliva testing kits for people interested in their genetic history.
Source: Daily Express :: Finance Feed https://ift.tt/2LE4s7j
GSK’s US lab drive
GLAXOSMITHKLINE is investing £230million in a US gene profiling company 23andMe, best known for saliva testing kits for people interested in their genetic history.
Source: Daily Express :: Finance Feed https://ift.tt/2LE4s7j
EmoticonEmoticon